Medigen Collaborates with Dynavax to Develop Novel Adjuvanted COVID-19 Vaccine Candidate
see more
2020/05/05
MVC Signed an License Agreement with NIH on COVID-19 Vaccine
see more
2020/04/30
MVC SARS-CoV-2 qPCR Kit Obtained CE Marking and Taiwan MOHW's Approval of Specific Medical Device's Manufacturing
see more
2020/04/08
MVC Announces Results from Phase II Study for Dengue Vaccine
see more
2020/02/17
MVC and NIH Collaborate to Develop COVID-19 Vaccine
see more
2019/12/25
MVC Completed Enrollment of Phase III MRCT For EV71 Vaccine
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies.
Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.